Cargando…

The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years

STUDY OBJECTIVE: The aim of this study is to elaborate the changes of the surgical approach of treatment for uterine myomas in Yangpu Hospital in the past 15 years. DESIGN: This was retrospective cohort study. SETTING: Yangpu Hospital, Tongji University School of Medicine, Shanghai, China. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Weihong, Luo, Ning, Ma, Lishan, Dai, Hong, Cheng, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135150/
https://www.ncbi.nlm.nih.gov/pubmed/30254928
http://dx.doi.org/10.4103/GMIT.GMIT_11_17
_version_ 1783354780838526976
author Yang, Weihong
Luo, Ning
Ma, Lishan
Dai, Hong
Cheng, Zhongping
author_facet Yang, Weihong
Luo, Ning
Ma, Lishan
Dai, Hong
Cheng, Zhongping
author_sort Yang, Weihong
collection PubMed
description STUDY OBJECTIVE: The aim of this study is to elaborate the changes of the surgical approach of treatment for uterine myomas in Yangpu Hospital in the past 15 years. DESIGN: This was retrospective cohort study. SETTING: Yangpu Hospital, Tongji University School of Medicine, Shanghai, China. MATERIALS AND METHODS: A total of 4113 patients with symptomatic uterine myomas underwent surgical treatments. Interventions: Eight kinds of different surgeries were involved in the study, including abdominal or laparoscopic surgery, hysterectomy, or uterus-sparing myomectomy. MEASUREMENTS: The study collected patients' clinical data and reviewed surgical access and approach, complications, and the results of following up. RESULTS: A total of 1559 cases (37.9%) underwent uterus-sparing myomectomy, 3005 cases (73.1%) performed laparoscopic surgeries. The percentage of laparoscopic surgery was significantly higher than homochronous data of laparotomy after 2003 (P < 0.001). The per year total of uterus-reserved surgery was proved to be negatively correlated with patient's age (R(2) = 0.930; P < 0.001). The rate of myomas recurrence was significantly lower in the combined myomectomy and uterine artery occlusion group (4%, 34/910) than in the single myomectomy group (10.5%, 44/420) (P < 0.001). CONCLUSIONS: Retaining uterus and minimally invasive surgery were the important trends of surgical treatment for symptomatic uterine myomas. Laparoscopic uterus-sparing myomectomy may be an alternative to hysterectomy to manage to appropriate patients with uterine myomas.
format Online
Article
Text
id pubmed-6135150
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-61351502018-09-24 The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years Yang, Weihong Luo, Ning Ma, Lishan Dai, Hong Cheng, Zhongping Gynecol Minim Invasive Ther Original Article STUDY OBJECTIVE: The aim of this study is to elaborate the changes of the surgical approach of treatment for uterine myomas in Yangpu Hospital in the past 15 years. DESIGN: This was retrospective cohort study. SETTING: Yangpu Hospital, Tongji University School of Medicine, Shanghai, China. MATERIALS AND METHODS: A total of 4113 patients with symptomatic uterine myomas underwent surgical treatments. Interventions: Eight kinds of different surgeries were involved in the study, including abdominal or laparoscopic surgery, hysterectomy, or uterus-sparing myomectomy. MEASUREMENTS: The study collected patients' clinical data and reviewed surgical access and approach, complications, and the results of following up. RESULTS: A total of 1559 cases (37.9%) underwent uterus-sparing myomectomy, 3005 cases (73.1%) performed laparoscopic surgeries. The percentage of laparoscopic surgery was significantly higher than homochronous data of laparotomy after 2003 (P < 0.001). The per year total of uterus-reserved surgery was proved to be negatively correlated with patient's age (R(2) = 0.930; P < 0.001). The rate of myomas recurrence was significantly lower in the combined myomectomy and uterine artery occlusion group (4%, 34/910) than in the single myomectomy group (10.5%, 44/420) (P < 0.001). CONCLUSIONS: Retaining uterus and minimally invasive surgery were the important trends of surgical treatment for symptomatic uterine myomas. Laparoscopic uterus-sparing myomectomy may be an alternative to hysterectomy to manage to appropriate patients with uterine myomas. Medknow Publications & Media Pvt Ltd 2018 2018-02-16 /pmc/articles/PMC6135150/ /pubmed/30254928 http://dx.doi.org/10.4103/GMIT.GMIT_11_17 Text en Copyright: © 2018 Gynecology and Minimally Invasive Therapy http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Yang, Weihong
Luo, Ning
Ma, Lishan
Dai, Hong
Cheng, Zhongping
The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years
title The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years
title_full The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years
title_fullStr The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years
title_full_unstemmed The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years
title_short The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years
title_sort changes of surgical treatment for symptomatic uterine myomas in the past 15 years
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135150/
https://www.ncbi.nlm.nih.gov/pubmed/30254928
http://dx.doi.org/10.4103/GMIT.GMIT_11_17
work_keys_str_mv AT yangweihong thechangesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT luoning thechangesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT malishan thechangesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT daihong thechangesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT chengzhongping thechangesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT yangweihong changesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT luoning changesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT malishan changesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT daihong changesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years
AT chengzhongping changesofsurgicaltreatmentforsymptomaticuterinemyomasinthepast15years